Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]

View source ↗

Summary

A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory autoimmune diseases, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Antiphospholipid Syndrome
• Inflammatory Myopathy
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• BRL-301 (BRL-301 CAR-T cells)

Snippet

Sponsor: Bioray Laboratories | Conditions: Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome | NA | Status: ENROLLING_BY_INVITATION